Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?
Lai E, Astara G, Ziranu P, Pretta A, Migliari M, Dubois M, Donisi C, Mariani S, Liscia N, Impera V, Persano M, Tolu S, Balconi F, Pinna G, Spanu D, Pireddu A, Saba G, Camera S, Musio F, Puzzoni M, Pusceddu V, Madeddu C, Casadei Gardini A, Scartozzi M. Lai E, et al. Among authors: impera v. Crit Rev Oncol Hematol. 2021 Jan;157:103167. doi: 10.1016/j.critrevonc.2020.103167. Epub 2020 Nov 12. Crit Rev Oncol Hematol. 2021. PMID: 33271389 Review.
New therapeutic targets in pancreatic cancer.
Lai E, Puzzoni M, Ziranu P, Pretta A, Impera V, Mariani S, Liscia N, Soro P, Musio F, Persano M, Donisi C, Tolu S, Balconi F, Pireddu A, Demurtas L, Pusceddu V, Camera S, Sclafani F, Scartozzi M. Lai E, et al. Among authors: impera v. Cancer Treat Rev. 2019 Dec;81:101926. doi: 10.1016/j.ctrv.2019.101926. Epub 2019 Nov 11. Cancer Treat Rev. 2019. PMID: 31739115 Review.
Uncovering key targets of success for immunotherapy in pancreatic cancer.
Pretta A, Lai E, Persano M, Donisi C, Pinna G, Cimbro E, Parrino A, Spanu D, Mariani S, Liscia N, Dubois M, Migliari M, Impera V, Saba G, Pusceddu V, Puzzoni M, Ziranu P, Scartozzi M. Pretta A, et al. Among authors: impera v. Expert Opin Ther Targets. 2021 Nov;25(11):987-1005. doi: 10.1080/14728222.2021.2010044. Epub 2021 Dec 13. Expert Opin Ther Targets. 2021. PMID: 34806517
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients.
Puzzoni M, Ziranu P, Demurtas L, Lai E, Mariani S, Liscia N, Soro P, Pretta A, Impera V, Camera S, Musio F, Persano M, Donisi C, Tolu S, Balconi F, Scartozzi M. Puzzoni M, et al. Among authors: impera v. Future Oncol. 2020 Jan;16(2):4337-4339. doi: 10.2217/fon-2019-0624. Epub 2019 Dec 3. Future Oncol. 2020. PMID: 31793396 No abstract available.
Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer.
Lai E, Liscia N, Donisi C, Mariani S, Tolu S, Pretta A, Persano M, Pinna G, Balconi F, Pireddu A, Impera V, Dubois M, Migliari M, Spanu D, Saba G, Camera S, Musio F, Ziranu P, Puzzoni M, Demurtas L, Pusceddu V, Dettori M, Massa E, Atzori F, Dessì M, Astara G, Madeddu C, Scartozzi M. Lai E, et al. Among authors: impera v. Cancers (Basel). 2020 May 13;12(5):1214. doi: 10.3390/cancers12051214. Cancers (Basel). 2020. PMID: 32413973 Free PMC article. Review.
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.
Pretta A, Ziranu P, Puzzoni M, Lai E, Orsi G, Liscia N, Molinaro E, Mariani S, Riggi L, Rovesti G, Dubois M, Migliari M, Persano M, Saba G, Impera V, Musio F, Batzella E, Demurtas L, Pusceddu V, Astara G, Faloppi L, Casadei Gardini A, Andrikou K, Cascinu S, Scartozzi M. Pretta A, et al. Among authors: impera v. Tumori. 2021 Dec;107(6):550-555. doi: 10.1177/0300891620976945. Epub 2020 Nov 26. Tumori. 2021. PMID: 33243068
Immune Checkpoint Inhibitors in the Treatment of HCC.
Donisi C, Puzzoni M, Ziranu P, Lai E, Mariani S, Saba G, Impera V, Dubois M, Persano M, Migliari M, Pretta A, Liscia N, Astara G, Scartozzi M. Donisi C, et al. Among authors: impera v. Front Oncol. 2021 Jan 7;10:601240. doi: 10.3389/fonc.2020.601240. eCollection 2020. Front Oncol. 2021. PMID: 33585218 Free PMC article. Review.
BRAF-mutant colorectal cancer, a different breed evolving.
Lai E, Pretta A, Impera V, Mariani S, Giampieri R, Casula L, Pusceddu V, Coni P, Fanni D, Puzzoni M, Demurtas L, Ziranu P, Faa G, Scartozzi M. Lai E, et al. Among authors: impera v. Expert Rev Mol Diagn. 2018 Jun;18(6):499-512. doi: 10.1080/14737159.2018.1470928. Epub 2018 May 9. Expert Rev Mol Diagn. 2018. PMID: 29708446 Review.